Nilo Therapeutics
A neuronal circuit regulates the immune system. We're targeting it to treat autoimmune and inflammatory diseases.
$101M Series A ·
Led by DCVC Bio · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMar 1, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $101M | fundraisingfox.com |
Timeline
- Website created
Team
KS
Kim Seth Chief Executive OfficerLK
Laurens Kruidenier Chief Scientific Officer
Investors
AAlexandria Venture Investments
BBill & Melinda Gates Foundation
DDCVC Biolead investor
LLux Capitallead investor
TThe Column Grouplead investor
Companies like Nilo Therapeutics
FFlip TherapeuticsSeed · Sep 2026
CCitryll$92.5M Series B+ · Dec 2024
ZZag BioSeries A
DDiadem Biotherapeutics
MMirador Therapeutics$250M Series B+ · Jan 2026
MMozart Therapeutics$25M Series A · Jun 2023
Other companies backed by DCVC Bio
LLatus Bio$97M Series A · May 2026
AAgZen$10M Series B+ · Mar 2026
GGrove Biopharma$30M Series A · Apr 2025
UUmoja Biopharma$100M Series B+ · Jan 2025
NnChroma Bio$75M · Dec 2024
UUnlearn$50M Series B+ · Feb 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nilo-therapeutics (get a free API key).